Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 21, 2014; 20(15): 4421-4427
Published online Apr 21, 2014. doi: 10.3748/wjg.v20.i15.4421
Published online Apr 21, 2014. doi: 10.3748/wjg.v20.i15.4421
Clinical characteristic | CCL2 expression level | P value1 | |
High | Low | ||
Gender | 0.091 | ||
Male | 36 | 14 | |
Female | 9 | 9 | |
Age (yr) | 0.772 | ||
< 49.82 | 16 | 9 | |
≥ 49.82 | 29 | 14 | |
Tumor diameter (cm) | 0.595 | ||
≤ 5 | 8 | 2 | |
5-10 | 8 | 5 | |
> 10 | 29 | 16 | |
Differentiation grade | 0.571 | ||
Well | 2 | 2 | |
Moderate | 16 | 10 | |
Poor | 27 | 11 | |
Histopathology | 0.387 | ||
Tubular | 14 | 6 | |
Poorly | 19 | 11 | |
Signet-ring | 7 | 1 | |
Mucinous | 5 | 5 | |
Lymph node metastasis | 0.954 | ||
Yes | 14 | 7 | |
No | 31 | 16 | |
AJCC stage2 | 0.268 | ||
I/II | 21 | 14 | |
III/IV | 24 | 9 |
- Citation: Tao LL, Shi SJ, Chen LB, Huang GC. Expression of monocyte chemotactic protein-1/CCL2 in gastric cancer and its relationship with tumor hypoxia. World J Gastroenterol 2014; 20(15): 4421-4427
- URL: https://www.wjgnet.com/1007-9327/full/v20/i15/4421.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i15.4421